United Therapeutics buy Wells Fargo & Company
Start price
08.12.23
/
50%
€224.60
Target price
08.12.24
€287.40
Performance (%)
44.70%
Price
29.08.24
€325.20
Summary
This prediction is currently active. With a performance of 44.70% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
United Therapeutics | 4.164% | 4.164% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by Wells_Fargo___Compan for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $309.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€314.10
20.08.24
20.08.24
€341.89
20.08.25
20.08.25
3.53%
29.08.24
29.08.24
United Therapeutics
Start price
Target price
Perf. (%)
€255.70
12.06.24
12.06.24
€323.16
12.06.25
12.06.25
27.18%
29.08.24
29.08.24
United Therapeutics
Start price
Target price
Perf. (%)
€220.00
07.03.24
07.03.24
€298.84
07.03.25
07.03.25
47.82%
29.08.24
29.08.24